Anish M. John

Insider Reports History

Location: Irvine, CA
Signature: /s/ Anish John
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Anish M. John:

Form 4 holding Chief Financial Officer

Oncocyte Corp

Security class: Option to Purchase Common Stock
Shares / value: 121,381
Estimated value
Report date: 24 Feb 2023
Price
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Insider Reports Filed by Anish M. John

4 OCX

Oncocyte Corp

Report period: 24 Feb 2023
Transactions: 1
Transaction value: $0
Filing time: 28 Feb 2023, 16:55
Role: Chief Financial Officer
Next action: Open filing details

4 OCX

Oncocyte Corp

Report period: 17 Jan 2023
Transactions: 1
Transaction value: $0
Filing time: 19 Jan 2023, 16:14
Role: Chief Financial Officer
Next action: Open filing details

4 OCX

Oncocyte Corp

Report period: 15 Aug 2022
Transactions: 2
Transaction value: $0
Filing time: 17 Aug 2022, 20:19
Role: Chief Financial Officer
Next action: Open filing details

4 OCX

Oncocyte Corp

Report period: 01 Jun 2022
Transactions: 1
Transaction value: $0
Filing time: 15 Jun 2022, 19:49
Role: SVP, Finance, and Interim CFO
Next action: Open filing details

3 OCX

Oncocyte Corp

Report period: 01 Jun 2022
Transactions: 0
Transaction value: $0
Filing time: 13 Jun 2022, 17:50
Role: SVP, Finance, and Interim CFO
Next action: Open filing details

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .